- AU$3.43m
- AU$3.30m
- AU$2.72m
- 49
- 46
- 21
- 34
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.42 | ||
| Price to Tang. Book | 1.8 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.9 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -78.5% | ||
| Return on Equity | -61.6% | ||
| Operating Margin | -70.23% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 3.59 | 3.53 | 3.98 | 2.62 | 2.72 | n/a | n/a | -0.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Uscom Limited is a medical technology company. It specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. It has three suites of devices in the field of cardiac, vascular, and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities, and is used to guide treatment. The USCOM 1A device has applications in emergency, intensive care medicine and anesthesia. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms in the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. Its VENTITEST digital ultrasonic ventilator testing solution is a new system for testing ventilators.
Directors
- Robert Phillips CHM
- Nick Schicht GMG
- Steve Haken OTH
- Denise Pater OTH
- Brett Crowley SEC
- Christian Bernecker NED
- Meng Xianhui NED
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 23rd, 1999
- Public Since
- December 10th, 2003
- No. of Shareholders
- 552
- No. of Employees
- 11
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 190,533,556
- Address
- L 8 66 Clarence Street, SYDNEY, 2000
- Web
- https://www.uscom.com.au/
- Phone
- +61 292474144
- Auditors
- BDO Audit Pty Ltd
Upcoming Events for UCM
Similar to UCM
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Uscom share price?
As of Today at 23:57 UTC, shares in Uscom are trading at AU$0.02. This share price information is delayed by 15 minutes.
How has the Uscom share price performed this year?
Shares in Uscom last closed at AU$0.02 and the price had moved by -65.22% over the past 365 days. In terms of relative price strength the Uscom share price has underperformed the ASX All Ordinaries Index by -68.32% over the past year.
What are the analyst and broker recommendations for Uscom?
There is no consensus recommendation for this security.
What is the Uscom dividend yield?
Uscom does not currently pay a dividend.
Does Uscom pay a dividend?
Uscom does not currently pay a dividend.
When does Uscom next pay dividends?
Uscom does not currently pay a dividend.
How do I buy Uscom shares?
To buy shares in Uscom you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Uscom?
As of the previous close price of AU$0.02, shares in Uscom had a market capitalisation of AU$3.05m.
Where are Uscom shares listed?
Here are the trading details for Uscom:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: UCM
What kind of share is Uscom?
Based on an overall assessment of its quality, value and momentum Uscom is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Uscom share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Uscom share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Uscom. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -61.85%.
As of the last closing price of AU$0.02, shares in Uscom were trading -69.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Uscom PE Ratio?
The Uscom PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Uscom?
Uscom's management team is headed by:
- Robert Phillips - CHM
- Nick Schicht - GMG
- Steve Haken - OTH
- Denise Pater - OTH
- Brett Crowley - SEC
- Christian Bernecker - NED
- Meng Xianhui - NED